Edwards Lifesciences Corp at JPMorgan Healthcare Conference Transcript
Welcome, everyone. I'm Robbie Marcus, the Med Tech Analyst at JPMorgan. Very happy to introduce our next speaker, Bernard Zovighian at Edwards.
Bernard is going to do a presentation followed by some Q&A. All right.
Thank you, Robbie, for us [here]. Good morning, everyone. Great to see our view. I'm very excited to share with you the vision we have for the company in 2026 and beyond.
We'll be making some forward-looking statements, which involve risk. They are all listed on our website and filed with the SEC. We will be also using non-GAAP financial measures, the reconciliation are available on our website.
In the last three years, our focus on -- solely on structural heart, give us an opportunity to deploy our strategy with speed and agility, and speed and agility across our core platforms. So TAVR, TMTT, so mitral and tricuspid and surgical, where we will continue to invest and bring next-gen innovation, because
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
